<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingJeffrey A. Engelman, Pasi A. Jänne, Courtney Hyland et al.|Science|2007Cited by 4.5k
Analysis of <i>Epidermal Growth Factor Receptor</i> Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to GefitinibTakayuki Kosaka, Tetsuya Mitsudomi, Yasushi Yatabe et al.|Clinical Cancer Research|2006Cited by 589